A Prospective Study of the NUVANCE Facial Rejuvenation System for Mid-Face, Neck and Jowl Rejuvenation Procedures

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-01

Study Completion Date

2014-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the clinical tolerability of the NUVANCE™ Facial Rejuvenation System for correcting neck, mid-face and/or jowl ptosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region

NCT04146467

Lax Skin

COMPLETED NA

Collagen Injections for the Treatment of Acne Scars and Wrinkles

NCT01704209

Acne Scars Wrinkles

TERMINATED PHASE1

Evaluation of the Ulthera® System for Treatment of the Face and Neck

NCT01713907

Wrinkles Rhytids Skin Laxity

TERMINATED NA

Bipolar RF Microneedling for Improved Laxity and Lift of the Submental and Neck Tissue and Effect on Elastin

NCT04245696

Skin Laxity

WITHDRAWN NA

A Single-Center, Open-Label, Exploratory Study of the Volumizing Effect of SCULPTRA Measured by Three Dimensional Digital Surface Imaging

NCT00487474

Mid Facial Contour Deficiencies

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multicenter, prospective, single-arm study. The primary tolerability endpoint will be evaluated up to 30-days post-operatively. Secondary endpoints will be evaluated at 6-months. Extended follow-up will be conducted at 12-months, 24-months, and 36-months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ptosis of the Neck, Mid-face and/or Jowl

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NUVANCE Facial Rejuvenation System

Group Type EXPERIMENTAL

NUVANCE Facial Rejuvenation System

Intervention Type DEVICE

The NUVANCE™ Facial Rejuvenation System is a partially absorbable porous mesh device implant with applicator.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NUVANCE Facial Rejuvenation System

The NUVANCE™ Facial Rejuvenation System is a partially absorbable porous mesh device implant with applicator.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female subject older than 18 years.
* Subject is a candidate for minimally invasive, bilateral facial rejuvenation procedure using NUVANCETM Facial Rejuvenation System according to the device Instructions for Use (IFU).
* Subject is willing and able to provide informed consent and follow study-related requirements.

Exclusion Criteria

* Subject who previously received surgical facial cosmetic treatment (procedure involving an incision):

1. Within the last 12 months under the area of the forehead;
2. Within the last 3 months within the area of the forehead where forehead is defined as the area above the imaginary anatomical line between the lateral canthus of the eye and the upper pole of the ear.
* Subject who previously received a cosmetic procedure with a dermal filler device and/or neurotoxin complex injectable within the last 9 months.
* Subjects with a permanent facial implant.
* Subjects planning on a cosmetic procedure with a permanent implant within 6-months of procedure.
* Subjects planning on a cosmetic procedure with a dermal filler device and/or neurotoxin complex injectable within 6-months of procedure.
* Subjects with significant ptosis where skin excision would be necessary.
* Subject has an active infection (e.g. acne, herpes zoster) or inflammation (e.g. psoriasis, pemphigus vulgaris, cutaneous lupus erythematosus) affecting facial skin.
* Subject has a history of a disorder that can affect wound healing (e.g. subjects pre-disposed to infection or history of keloid formation).
* Subject with pre-existing facial abnormalities (e.g. deformities, Bell's palsy, scarring)
* Subject with a significant psychiatric disorder judged by the clinical investigator that will interfere with the procedure
* Any pre-operative findings that the surgeon identifies that makes the subject not a candidate for a minimally invasive facial cosmetic surgical procedure.

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No